CareDx (CDNA) stock price, chart and financials
Price chart
Financials
- Revenue (quarter)
- $131.9M
- Gross margin
- 70.58%
- Net income (quarter)
- $110.6M
- Net income growth (year over year)
- +1391.27%
- Net margin
- 24.23%
- Return on equity
- 29.49%
- Book value per share
- $8.27
- Price to book
- 7.86
- Debt to assets
- 20.15%
Company profile
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Frequently asked questions
Is CareDx (CDNA) profitable?
Yes. CareDx earned $111.0M in net income over the trailing twelve months, a net margin of 24.23%.
How much revenue does CareDx (CDNA) make?
CareDx generated $458.1M in revenue over the trailing twelve months, up 52.23% year over year.
What is CDNA's P/E ratio?
CareDx trades at 30.1 times trailing twelve-month earnings, on an EPS of $2.16.
How do I buy stock in CareDx (CDNA)?
CDNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
